Announcements Trials
Browse Landscape

Status

Completed 76Terminated 22Withdrawn 8Unknown 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Drug Therapy 108Cisplatin 96Radiotherapy 87Carboplatin 84Bevacizumab 81Oxaliplatin 72tislelizumab 69Capecitabine 67Cyclophosphamide 65Gemcitabine 63toripalimab 60Paclitaxel 59sintilimab 55Specimen Handling 55pembrolizumab 54Surgical Procedures, Operative 51Magnetic Resonance Spectroscopy 49Fluorouracil 48anlotinib 47Immune Checkpoint Inhibitors 45Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 37camrelizumab 36lenvatinib 34fludarabine 34Radiosurgery 33Leucovorin 32venetoclax 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Gene Expression Profiling × Clear all
NCT03127111 2022-03-15

Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

Renmin Hospital of Wuhan University

Not yet recruiting
300 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡